437 related articles for article (PubMed ID: 27503707)
1. Ultrasound-guided therapeutic modulation of hepatocellular carcinoma using complementary microRNAs.
Mullick Chowdhury S; Wang TY; Bachawal S; Devulapally R; Choe JW; Abou Elkacem L; Yakub BK; Wang DS; Tian L; Paulmurugan R; Willmann JK
J Control Release; 2016 Sep; 238():272-280. PubMed ID: 27503707
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal assessment of ultrasound-guided complementary microRNA therapy of hepatocellular carcinoma.
Chowdhury SM; Lee T; Bachawal SV; Devulapally R; Abou-Elkacem L; Yeung TA; Wischhusen J; Tian L; Dahl J; Paulmurugan R; Willmann JK
J Control Release; 2018 Jul; 281():19-28. PubMed ID: 29758233
[TBL] [Abstract][Full Text] [Related]
3. Ultrasound-guided delivery of microRNA loaded nanoparticles into cancer.
Wang TY; Choe JW; Pu K; Devulapally R; Bachawal S; Machtaler S; Chowdhury SM; Luong R; Tian L; Khuri-Yakub B; Rao J; Paulmurugan R; Willmann JK
J Control Release; 2015 Apr; 203():99-108. PubMed ID: 25687306
[TBL] [Abstract][Full Text] [Related]
4. Ultrasound-Guided Microbubble-Mediated Locoregional Delivery of Multiple MicroRNAs Improves Chemotherapy in Hepatocellular Carcinoma.
Wang H; Hu Z; Sukumar UK; Bose RJ; Telichko A; Dahl JJ; Paulmurugan R
Nanotheranostics; 2022; 6(1):62-78. PubMed ID: 34976581
[No Abstract] [Full Text] [Related]
5. MiR-375 delivered by lipid-coated doxorubicin-calcium carbonate nanoparticles overcomes chemoresistance in hepatocellular carcinoma.
Zhao P; Wu S; Cheng Y; You J; Chen Y; Li M; He C; Zhang X; Yang T; Lu Y; Lee RJ; He X; Xiang G
Nanomedicine; 2017 Nov; 13(8):2507-2516. PubMed ID: 28577837
[TBL] [Abstract][Full Text] [Related]
6. miR-221 suppression through nanoparticle-based miRNA delivery system for hepatocellular carcinoma therapy and its diagnosis as a potential biomarker.
Li F; Wang F; Zhu C; Wei Q; Zhang T; Zhou YL
Int J Nanomedicine; 2018; 13():2295-2307. PubMed ID: 29713162
[TBL] [Abstract][Full Text] [Related]
7. Gemcitabine and Antisense-microRNA Co-encapsulated PLGA-PEG Polymer Nanoparticles for Hepatocellular Carcinoma Therapy.
Devulapally R; Foygel K; Sekar TV; Willmann JK; Paulmurugan R
ACS Appl Mater Interfaces; 2016 Dec; 8(49):33412-33422. PubMed ID: 27960411
[TBL] [Abstract][Full Text] [Related]
8. Glycyrrhetinic acid-decorated and reduction-sensitive micelles to enhance the bioavailability and anti-hepatocellular carcinoma efficacy of tanshinone IIA.
Chen F; Zhang J; He Y; Fang X; Wang Y; Chen M
Biomater Sci; 2016 Jan; 4(1):167-82. PubMed ID: 26484363
[TBL] [Abstract][Full Text] [Related]
9. Targeted hepatocellular carcinoma therapy: transferrin modified, self-assembled polymeric nanomedicine for co-delivery of cisplatin and doxorubicin.
Zhang X; Li J; Yan M
Drug Dev Ind Pharm; 2016 Oct; 42(10):1590-9. PubMed ID: 26942448
[TBL] [Abstract][Full Text] [Related]
10. Ultrasound/microbubble-mediated targeted delivery of anticancer microRNA-loaded nanoparticles to deep tissues in pigs.
Di Ianni T; Bose RJC; Sukumar UK; Bachawal S; Wang H; Telichko A; Herickhoff C; Robinson E; Baker S; Vilches-Moure JG; Felt SA; Gambhir SS; Paulmurugan R; Dahl JD
J Control Release; 2019 Sep; 309():1-10. PubMed ID: 31326463
[TBL] [Abstract][Full Text] [Related]
11. Ultrasound-Mediated Gene Therapy of Hepatocellular Carcinoma Using Pre-microRNA Plasmid-Loaded Nanodroplets.
Dong W; Wu P; Zhou D; Huang J; Qin M; Yang X; Wan M; Zong Y
Ultrasound Med Biol; 2020 Jan; 46(1):90-107. PubMed ID: 31668943
[TBL] [Abstract][Full Text] [Related]
12. Ultrasound-Assisted miR-122-Loaded Polymeric Nanodroplets for Hepatocellular Carcinoma Gene Therapy.
Guo H; Xu M; Cao Z; Li W; Chen L; Xie X; Wang W; Liu J
Mol Pharm; 2020 Feb; 17(2):541-553. PubMed ID: 31876426
[TBL] [Abstract][Full Text] [Related]
13. Differential miRNA expression profiles in hepatocellular carcinoma cells and drug-resistant sublines.
Zhuo L; Liu J; Wang B; Gao M; Huang A
Oncol Rep; 2013 Feb; 29(2):555-62. PubMed ID: 23229111
[TBL] [Abstract][Full Text] [Related]
14. MiR-101 and doxorubicin codelivered by liposomes suppressing malignant properties of hepatocellular carcinoma.
Xu F; Liao JZ; Xiang GY; Zhao PX; Ye F; Zhao Q; He XX
Cancer Med; 2017 Mar; 6(3):651-661. PubMed ID: 28135055
[TBL] [Abstract][Full Text] [Related]
15. Multipotent miRNA Sponge-Loaded Magnetic Nanodroplets with Ultrasound/Magnet-Assisted Delivery for Hepatocellular Carcinoma Therapy.
Dong W; Wu P; Qin M; Guo S; Liu H; Yang X; He W; Bouakaz A; Wan M; Zong Y
Mol Pharm; 2020 Aug; 17(8):2891-2910. PubMed ID: 32678617
[TBL] [Abstract][Full Text] [Related]
16. PLGA-based dual targeted nanoparticles enhance miRNA transfection efficiency in hepatic carcinoma.
Cai C; Xie Y; Wu L; Chen X; Liu H; Zhou Y; Zou H; Liu D; Zhao Y; Kong X; Liu P
Sci Rep; 2017 Apr; 7():46250. PubMed ID: 28387375
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
[TBL] [Abstract][Full Text] [Related]
18. Ultrasound-mediated delivery of miRNA-122 and anti-miRNA-21 therapeutically immunomodulates murine hepatocellular carcinoma in vivo.
Wischhusen JC; Chowdhury SM; Lee T; Wang H; Bachawal S; Devulapally R; Afjei R; Sukumar UK; Paulmurugan R
J Control Release; 2020 May; 321():272-284. PubMed ID: 32004588
[TBL] [Abstract][Full Text] [Related]
19. Improved therapeutic effect of DOX-PLGA-PEG micelles decorated with bivalent fragment HAb18 F(ab')(2) for hepatocellular carcinoma.
Jin C; Qian N; Zhao W; Yang W; Bai L; Wu H; Wang M; Song W; Dou K
Biomacromolecules; 2010 Sep; 11(9):2422-31. PubMed ID: 20831277
[TBL] [Abstract][Full Text] [Related]
20. Fabrication, optimization, and characterization of umbelliferone β-D-galactopyranoside-loaded PLGA nanoparticles in treatment of hepatocellular carcinoma: in vitro and in vivo studies.
Kumar V; Bhatt PC; Rahman M; Kaithwas G; Choudhry H; Al-Abbasi FA; Anwar F; Verma A
Int J Nanomedicine; 2017; 12():6747-6758. PubMed ID: 28932118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
